Camber Capital Management LLC 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 08:34 am Sale |
2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LLC | 0 0.000% |
-2,805,000 (Position Closed) |
Filing |
| 2024-02-14 08:19 am Sale |
2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LLC | 2,805,000 5.900% |
-1,430,000 (-33.77%) |
Filing |
| 2023-02-14 08:30 am Purchase |
2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LLC | 4,235,000 9.280% |
2,185,000 (+106.59%) |
Filing |
| 2022-02-14 09:35 am Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LLC | 2,050,000 5.010% |
-505,000 (-19.77%) |
Filing |
| 2021-02-16 08:21 am Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LLC | 2,555,000 6.430% |
155,000 (+6.46%) |
Filing |
| 2020-06-29 6:03 pm Purchase |
2020-06-18 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LLC | 2,400,000 6.100% |
2,400,000 (New Position) |
Filing |